Request Deal Involvement
Alcon to acquire EYSUVIS and INVELTYS from Kala Pharmaceuticals for $60m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
WilmerHale
financial advisors
Piper Sandler
pr advisors
Precision AQ
or
Principals
target
EYSUVIS
bidder
ALCON INC
vendor
KALA PHARMACEUTICALS
target
INVELTYS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite